188 related articles for article (PubMed ID: 28173638)
1. Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review.
Riker RR; Gagnon DJ; Hatton C; May T; Seder DB; Stokem K; Fraser GL
Pharmacotherapy; 2017 Apr; 37(4):500-508. PubMed ID: 28173638
[TBL] [Abstract][Full Text] [Related]
2. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML
Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Free Valproate Concentration in Critically Ill Patients.
Brown CS; Liu J; Riker RR; Mara KC; Rabinstein AA; Fraser GL; May TL; Seder D; Gagnon DJ
Crit Care Explor; 2022 Sep; 4(9):e0746. PubMed ID: 37942235
[TBL] [Abstract][Full Text] [Related]
4. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
de Maat MM; van Leeuwen HJ; Edelbroek PM
Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
[TBL] [Abstract][Full Text] [Related]
5. Decreased plasma protein binding of valproate in patients with acute head trauma.
Anderson GD; Gidal BE; Hendryx RJ; Awan AB; Temkin NR; Wilensky AJ; Winn HR
Br J Clin Pharmacol; 1994 Jun; 37(6):559-62. PubMed ID: 7917774
[TBL] [Abstract][Full Text] [Related]
6. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
McCabe PH; Michel NC; McNew CD; Lehman EB
Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
[TBL] [Abstract][Full Text] [Related]
7. Intravenous valproate dosing in neonates.
Alfonso I; Alvarez LA; Gilman J; Dunoyer C; Yelin K; Papazian O
J Child Neurol; 2000 Dec; 15(12):827-9. PubMed ID: 11198504
[TBL] [Abstract][Full Text] [Related]
8. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
[TBL] [Abstract][Full Text] [Related]
9. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
Dasgupta A; McLemore JL
Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
[TBL] [Abstract][Full Text] [Related]
10. Synergistic impact of low serum albumin on intensive care unit admission and high blood urea nitrogen during intensive care unit stay on post-intensive care unit mortality in critically ill elderly patients requiring mechanical ventilation.
Pan SW; Kao HK; Yu WK; Lien TC; Chen YW; Wang JH; Kou YR
Geriatr Gerontol Int; 2013 Jan; 13(1):107-15. PubMed ID: 22672187
[TBL] [Abstract][Full Text] [Related]
11. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
[TBL] [Abstract][Full Text] [Related]
12. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
13. Simulations of Valproate Doses Based on an External Evaluation of Pediatric Population Pharmacokinetic Models.
Tauzin M; Tréluyer JM; Nabbout R; Billette de Villemeur T; Desguerre I; Aboura R; Gana I; Zheng Y; Benaboud S; Bouazza N; Chenevier-Gobeaux C; Freihuber C; Hirt D
J Clin Pharmacol; 2019 Mar; 59(3):406-417. PubMed ID: 30412268
[TBL] [Abstract][Full Text] [Related]
14. Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients.
Sherr JD; Kelly DL
Psychiatr Serv; 1998 Oct; 49(10):1355-7. PubMed ID: 9779912
[TBL] [Abstract][Full Text] [Related]
15. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
Dutta S; Faught E; Limdi NA
J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin.
Drisaldi A; Weeda E; Neyens R; Orvin N; Bonilha L; Campbell Z; Bohm N
Neurocrit Care; 2019 Apr; 30(2):301-306. PubMed ID: 30328046
[TBL] [Abstract][Full Text] [Related]
17. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
[TBL] [Abstract][Full Text] [Related]
18. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients.
Van Matre ET; Cook AM
Neurol Res; 2016 Sep; 38(9):786-91. PubMed ID: 27414414
[TBL] [Abstract][Full Text] [Related]
19. Rapid infusion of sodium valproate in acutely ill children.
Birnbaum AK; Kriel RL; Norberg SK; Wical BS; Le DN; Leppik IE; Cloyd JC
Pediatr Neurol; 2003 Apr; 28(4):300-3. PubMed ID: 12849885
[TBL] [Abstract][Full Text] [Related]
20. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
